Related Experiment Video
Updated: Jun 13, 2026
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Dr. Jane C. Wright (1919-2013): The Architect of Modern Chemotherapy and Clinical Oncology
Muhammad Hamza Shah1,2,3
1Department of Internal Medicine, Antrim Area Hospital, Antrim, GBR.
Abstract:
Dr. Jane Cooke Wright (1919-2013) was a trailblazing African American surgeon-scientist who transformed cancer chemotherapy from an experimental last resort into a cornerstone of modern oncology. Over a career spanning 40 years, she and her collaborators pioneered human tissue-culture methods to test anti-cancer drugs, introduced nitrogen mustard and methotrexate therapies, and advocated for novel multi-drug combination regimens. Dr. Wright held major research and clinical leadership positions and was instrumental in the founding of many eminent organizations/bodies, including the Chemotherapy Department at New York Medical College and the American Society of Clinical Oncology (ASCO), which she co-founded in 1964. As an African American woman, she overcame pervasive racial and gender barriers to become the highest-ranking Black woman physician in U.S. medicine by the 1960s. This article reviews Dr. Wright's scientific contributions in chemotherapy development and clinical research, her personal and educational background (including the influence of her father, Dr. Louis T. Wright), and her enduring impact on cancer care and medical leadership.
More Related Videos
Related Concept Videos
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:03Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...